Locoregional Control and Mild Late Toxicity After Reducing Target Volumes and Radiation Doses in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy (IC) Followed by Concurrent Chemoradiotherapy: 10-Year Results of a Phase 2 Study-Reference-Cited by-同舟云学术

Locoregional Control and Mild Late Toxicity After Reducing Target Volumes and Radiation Doses in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy (IC) Followed by Concurrent Chemoradiotherapy: 10-Year Results of a Phase 2 Study

Published:2019-07 Issue:4 Volume:104 Page:836-844
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Zhao Chong,Miao Jing-Jing,Hua Yi-Jun,Wang Lin,Han Fei,Lu Li-Xia,Xiao Wei-Wei,Wu Hai-Jun,Zhu Man-Yi,Huang Shao-Min,Lin Cheng-Guang,Deng Xiao-Wu,Xie Cong-Hua

Funder

Science and Technology Project of Guangdong Province

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference32 articles.

1. The discipline of radiation oncology[M]. Perez and brady principles and practice of radiation oncology;Mcbride,2013

2. Nasopharyngeal carcinoma incidence and mortality in China, 2013;Wei;Chin J Cancer,2017

3. Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma;Hui;J Clin Oncol,2009

4. Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase 3, multicentre, randomised controlled trial;Sun;Lancet Oncol,2016

5. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicenter randomised controlled trial;Cao;Eur J Cancer,2017

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Value of Parapharyngeal Involvement Subclassifications Divided by Parapharyngeal Muscles in Nasopharyngeal Carcinoma: A Study of 1752 Patients from Two Centers;2024-05-09

2. The individualized delineation of clinical target volume for primary nasopharyngeal carcinoma based on invasion risk of substructures: A prospective, real-world study with a large population;Radiotherapy and Oncology;2024-05

3. Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines, Sixth Edition;The Journal of Laryngology & Otology;2024-03-14

4. Optimizing Cervical Target Volume in Patients with Nasopharyngeal Cancer Based On Nodal Drainage Distance;Clinical Cancer Research;2024-02-13

5. Embracing Personalized Strategies in Radiotherapy for Nasopharyngeal Carcinoma: Beyond the Conventional Bounds of Fields and Borders;Cancers;2024-01-16